Edifoligide
As of the edition of 20 October 2026, Edifoligide is a drug: stopped in 2005; acts on E2F1, E2F2 and E2F3 and 5 more.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Stopped, 2005
- Kind
- Unknown
- Registered trials
- 1, 1 stopped early
- Disease areas
- Pregnancy and women's health; Urinary and reproductive
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Targets
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 2 | 1 | 0 | 0 | 1 |
| All trials | 1 |
Who ran its trials
| Company | Role | Years |
|---|---|---|
| Anesiva | Lead sponsor of trials | 2004 to now |